The State of Utah v. APOTEX CORPORATION; BAXTER HEALTHCARE CORPORATION; BOEHRINGERINGELHEIM CORPORATION; MALLINCKRODT INC.; CSL BEHRING; FOREST LABORATORIES, INC.; MORTON GROVE PHARMACEUTICALS, INC.; MUTUAL PHARMACEUTICAL COMPANY, INC.; NOVARTIS PHARMACEUTICALS CORPORATION; OTSUKA AMERICA, INC.; PFIZER, INC.; QUALITEST PHARMACEUTICALS, INC.; SCHERING-PLOUGH CORPORATION; SCHWARZ PHARMA USA HOLDINGS, INC; TARO PHARMACEUTICALS USA, INC.; UPSHER-SMITH, INC.; and WYETH, INC., : Brief of Appellant

Authors

Utah Supreme Court

Docket Number

20100257.00

Document Type

Brief of Appellant

Publication Date

2010

Comments

Original Brief Submitted to the Utah Supreme Court; digitized by the Howard W. Hunter Law Library, J. Reuben Clark Law School, Brigham Young University, Provo, Utah; machine-generated OCR, may contain errors.
R. James DeRose, III; Locke, Lord, Bissell, and Liddell; Counsel for Appellees.
Joseph W. Steele; David C. Biggs; Special Assistant Attorneys General; Steele and Biggs, LLC.

Rights

Public record document (some rights may be reserved).

Recommended Citation

Brief of Appellant, Utah v. Apotex Corporation, No. 20100257.00 (Utah Supreme Court, 2010).
https://digitalcommons.law.byu.edu/byu_sc2/3030